Page last updated: 2024-09-05

tolvaptan and cholest-5-ene-3,4-diol

tolvaptan has been researched along with cholest-5-ene-3,4-diol in 1 studies

Compound Research Comparison

Studies (tolvaptan)	Trials (tolvaptan)	Recent Studies (post-2010) (tolvaptan)	Studies (cholest-5-ene-3,4-diol)	Trials (cholest-5-ene-3,4-diol)	Recent Studies (post-2010) (cholest-5-ene-3,4-diol)
967	172	786	94	16	77

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Akutsu, S; Hoshikawa, K; Kawakami, J; Maekawa, Y; Naito, T; Saotome, M	1

Other Studies

1 other study(ies) available for tolvaptan and cholest-5-ene-3,4-diol

Article	Year
Impact of CYP3A5 genotype on tolvaptan pharmacokinetics and their relationships with endogenous markers of CYP3A activity and serum sodium level in heart failure patients. Basic & clinical pharmacology & toxicology, 2020, Volume: 126, Issue:4 Topics: Aged; Aged, 80 and over; Alleles; Antidiuretic Hormone Receptor Antagonists; ATP Binding Cassette Transporter, Subfamily B; Cholesterol; Cytochrome P-450 CYP3A; Female; Genotype; Heart Failure; Humans; Hydroxycholesterols; Male; Sodium; Tolvaptan; Vitamin D	2020

Article

Year

Impact of CYP3A5 genotype on tolvaptan pharmacokinetics and their relationships with endogenous markers of CYP3A activity and serum sodium level in heart failure patients.

Basic & clinical pharmacology & toxicology, 2020, Volume: 126, Issue:4

Topics: Aged; Aged, 80 and over; Alleles; Antidiuretic Hormone Receptor Antagonists; ATP Binding Cassette Transporter, Subfamily B; Cholesterol; Cytochrome P-450 CYP3A; Female; Genotype; Heart Failure; Humans; Hydroxycholesterols; Male; Sodium; Tolvaptan; Vitamin D

2020